Cat. No. 5417
Chemical Name: N-[2-(Dimethylamino)ethyl]-12-oxo-1
Biological Activityp53 pathway activator; induces expression of p53 target genes. Also RNA polymerase 1 inhibitor; promotes degradation of RPA194. Reduces viability of multiple tumor cell lines and attenuates tumor growth of A375 melanoma cell xenografts in mice.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Colis et al (2014) Design, synthesis, and structure-activity relationships of pyridoquinazolinecarboxamides as RNA polymerase I inhibitors. J.Med.Chem. 57 4950. PMID: 24847734.
Peltonen et al (2014) A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer Cell 13 77. PMID: 24434211.
Peltonen et al (2010) Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agents. PLoS ONE 5 e12996. PMID: 20885994.
If you know of a relevant reference for BMH 21 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses BMH 21 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: BMH 21, supplier, BMH21, p53, pathway, activators, rna, polymerase, inhibitors, inhibits, RPA194, antitumor, Tocris Bioscience, RNA/DNA Polymerase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent PARP inhibitor; orally bioavailableEntecavir
Potent and selective hepatitis B virus inhibitorBRACO 19 trihydrochloride
August 20 - 24, 2017
Paris , France